Kangstem Biotech Co. Ltd (217730) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.059x

Based on the latest financial reports, Kangstem Biotech Co. Ltd (217730) has a cash flow conversion efficiency ratio of -0.059x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.81 Billion ≈ $-2.58 Million USD) by net assets (₩64.83 Billion ≈ $43.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Kangstem Biotech Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Kangstem Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Kangstem Biotech Co. Ltd for a breakdown of total debt and financial obligations.

Kangstem Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kangstem Biotech Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cohen & Steers Real Estate Opportunities and Income Fund NYSE:RLTY	N/A
INTEKPLUS Co. Ltd KQ:064290	-0.062x
Sagar Cements Limited NSE:SAGCEM	0.048x
Millenium Hotels Real Estate I SOCIMI S.A. MC:YMHRE	-0.005x
Invalda INVL AB STU:WTK	0.005x
Aekyung Industrial Co Ltd KO:018250	-0.005x
SFC Energy AG XETRA:F3C	0.054x
Crescendo Corporation Bhd KLSE:6718	-0.036x

Annual Cash Flow Conversion Efficiency for Kangstem Biotech Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of Kangstem Biotech Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 217730 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩43.18 Billion ≈ $29.26 Million	₩-18.99 Billion ≈ $-12.87 Million	-0.440x	-18.65%
2023-12-31	₩44.52 Billion ≈ $30.17 Million	₩-16.50 Billion ≈ $-11.18 Million	-0.371x	+7.15%
2022-12-31	₩47.26 Billion ≈ $32.03 Million	₩-18.86 Billion ≈ $-12.78 Million	-0.399x	-59.89%
2021-12-31	₩68.07 Billion ≈ $46.13 Million	₩-16.99 Billion ≈ $-11.52 Million	-0.250x	+7.92%
2020-12-31	₩51.62 Billion ≈ $34.98 Million	₩-13.99 Billion ≈ $-9.48 Million	-0.271x	-43.92%
2019-12-31	₩70.72 Billion ≈ $47.93 Million	₩-13.32 Billion ≈ $-9.03 Million	-0.188x	+21.73%
2018-12-31	₩47.69 Billion ≈ $32.32 Million	₩-11.48 Billion ≈ $-7.78 Million	-0.241x	+46.94%
2017-12-31	₩23.47 Billion ≈ $15.91 Million	₩-10.65 Billion ≈ $-7.22 Million	-0.454x	-33.67%
2016-12-31	₩22.98 Billion ≈ $15.57 Million	₩-7.80 Billion ≈ $-5.28 Million	-0.339x	-89.64%
2015-12-31	₩21.24 Billion ≈ $14.39 Million	₩-3.80 Billion ≈ $-2.58 Million	-0.179x	--

About Kangstem Biotech Co. Ltd

KQ:217730 Korea Biotechnology

Market Cap

$254.64 Million

₩375.75 Billion KRW

Market Cap Rank

#15620 Global

#603 in Korea

Share Price

₩3995.00

Change (1 day)

-1.11%

52-Week Range

₩1171.00 - ₩4615.00

All Time High

₩18836.30